go back

Chemo with Acute Leukemia as Sdx without Complications

Virginia rates for MS-DRG 839

Chemotherapy with Acute Leukemia as Secondary Diagnosis without CC/MCC

Rates data updated July 2026.

How much does Chemo with Acute Leukemia as Sdx without Complications cost?

$22,387

Typical facility fee. In Virginia, July 2026.

Insurers have agreed to pay about $22,387 for this service. Most negotiated rates run $18,197 to $27,542.

These are rates insurers have negotiated with providers, not the amount a patient is billed. What you owe depends on your plan's deductible and coinsurance. Based on rates published by 5 insurance carriers under federal price transparency rules.

How much rates vary

Facilitymedian $22,387 · 10th to 90th $15,136 to $32,359
$1.0K$2.0K$5.0K$10.0K$20.0K$50.0Kfacility $22,387

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$20,417.38
Median
$25,118.86
Typical High
$28,840.32
Anthem BCBS
Setting
Facility
Modifier
Global
Typical Low
$18,197.01
Median
$26,915.35
Typical High
$36,307.81
Cigna
Setting
Facility
Modifier
Global
Typical Low
$14,791.08
Median
$21,877.62
Typical High
$33,884.42
Sentara
Setting
Facility
Modifier
Global
Typical Low
$14,125.38
Median
$20,417.38
Typical High
$29,512.09
United
Setting
Facility
Modifier
Global
Typical Low
$4,073.80
Median
$19,952.62
Typical High
$39,810.72

Where Virginia sits

The same service costs 8.3 times more in Montana than in West Virginia. Every bar is a state, most expensive first. Pick one to see its carriers and full range.

Virginia $22,387 · 25th of 51
MT $72,444WV $8,710

Median negotiated rate in each state, from every insurer that publishes one. States where no insurer publishes a rate for this service are not shown.